Integrated analysis of single‐cell RNA ‐seq and bulk RNA ‐seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Siyuan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Foshan Stomatological Hospital, School of Medicine, Foshan University, Foshan, Guangdong, China. Hauptthemen laut MEDLINE: Single-Cell Analysis, Squamous Cell Carcinoma of Head and Neck, Macrophages, Tumor Microenvironment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
The connection between head and neck squamous cell carcinoma (HNSC) and M2 tumour‐associated macrophages is not yet fully understood. We gathered gene expression profiles and clinical data from HNSC patients in the TCGA database. Using Consensus Clustering, we categorized these patients into M2 macrophage‐related clusters. We developed a M2 macrophage‐related signature (MRS) through statistical analyses. Additionally, we assessed gene expression in HNSC cells using single‐cell sequencing data (GSE139324). We identified three distinct M2 macrophage‐related clusters in HNSC, each with different prognostic outcomes and immune characteristics. Patients with different MRS profiles exhibited variations in immune infiltration, genetic mutations and prognosis. FCGR2A may play a role in creating an immunosuppressive tumour microenvironment and could potentially serve as a therapeutic target for HNSC. Our study demonstrated that M2 macrophage‐related genes significantly impact the development and progression of HNSC. The M2 macrophage‐related model offered a more comprehensive assessment of HNSC patient prognosis, genetic mutations and immune features. FCGR2A was implicated in immunosuppressive microenvironments and may hold promise for the development of novel immunotherapeutic strategies for HNSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Foshan Stomatological Hospital, School of Medicine, Foshan University, Foshan, Guangdong, China.
- Department of Oral and Maxillofacial Surgery, ZhuJiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Stomatology, Foshan First People's Hospital, Foshan, Guangdong, China.
ORCID-Profile: Haigang Wei, Chen Zou, Yilong Ai
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wu, S., Lv, X., Wei, H., Wu, J., Liu, S., Li, X., Song, J., Zou, C., & Ai, Y. (2024). Integrated analysis of single‐cell RNA ‐seq and bulk RNA ‐seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18083
Vancouver
Wu S, Lv X, Wei H, Wu J, Liu S, Li X, et al. Integrated analysis of single‐cell RNA ‐seq and bulk RNA ‐seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18083
BibTeX
@article{Wu2024,
author = {Wu, Siyuan and Lv, Xiaozhi and Wei, Haigang and Wu, Jialin and Liu, Shiwei and Li, Xia and Song, Jing and Zou, Chen and Ai, Yilong},
title = {Integrated analysis of single‐cell RNA ‐seq and bulk RNA ‐seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18083}
}
EUVIMED